跳至主要内容
临床试验/ITMCTR2200005812
ITMCTR2200005812尚未招募1 期

A Randomized Controlled Study on the Effect of Acupuncture Intervention in Advance on the Efficacy of Moderate to Severe Seasonal Allergic Rhinitis

Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) Meet the diagnostic criteria of moderate and severe seasonal allergic rhinitis;
  • (2) Subjects with positive reactions to seasonal inhalation allergens such as pollen and fungi in skin prick test;
  • (3) Subjects with a history of seasonal allergic rhinitis for at least 2 yearswho have a fixed onset time each year and are currently in remission;
  • (4) The average total nasal symptom score(TNSS)=4 during the episode in the past year;
  • (5) Subjects aged between 18-65 years old;
  • (6) Subjects who volunteer to participate in the clinical study, and are able to answer relevant scale questions truthfully as required, recorded the use of anti-allergy drugs, and signed informed consent.
  • Only those who meet the above six items can be included.

排除标准

  • (1) Subjects who have a history of chronic paranasal sinusitis, or who are found to have chronic paranasal sinusitis by paranasal sinus X-ray examination;
  • (2) Subjects who have organic lesions in the nasal cavity or who have undergone nasal surgery;
  • (3) Subjects with respiratory tract infection or acute sinusitis within the past 2 weeks; patients with inflammation on chest X-ray;
  • (4) Subjects who have received western medicine (H1-antihistamines, glucocorticoids, leukotriene receptor antagonists, mast cell membrane stabilizers, decongestants and anticholinergics, etc.), traditional Chinese medicines, etc. via nasal cavity, oral cavity or systemic route in the past 2 weeks which may affect the results of clinical study;
  • (5) Subjects who have received physical therapy within the range of traditional medicine such as acupuncture, moxibustion, cupping, and intranasal Chinese medicine inhalation in the past 2 weeks;
  • (6) Subjects who have received specific immunotherapy or systemic hormone therapy within the past 1 year;
  • (7) Subjects complicated with other respiratory diseases, such as asthma, etc.;
  • (8) Subjects complicated with severe liver or kidney dysfunction or other serious diseases, who cannot receive treatment;
  • (9) People with serious mental illness or violent tendencies;
  • (10) Pregnant or lactating women, and women who are planning to become pregnant during the trial;
  • (11) Concurrently participating in other clinical trials.
  • Those who meet any of the above items will be excluded.

研究者

相似试验